logo
Humans have forced cod to shrink in size by half since 1990s, scientists find

Humans have forced cod to shrink in size by half since 1990s, scientists find

Independent2 days ago

Excessive fishing has forced Baltic cod to undergo genetic changes that have halved their size over the past 30 years, a new study has found.
The research, published in the journal Science Advances, is the first to show that decades of overfishing and environmental change can profoundly alter the genetic make-up of a fully marine species.
Baltic cod once measured more than a meter long and weighed up to 40kg, forming the backbone of the region's fishery. In the last three decades, however, the species has shrunk so much that even a full-grown cod can fit neatly on a dinner plate.
'For the first time in a fully marine species, we have provided evidence of evolutionary changes in the genomes of a fish population subjected to intense exploitation, which has pushed the population to the brink of collapse,' lead author Kwi Young Han said.
Researchers examined an archive of ear stones from 152 overexploited Eastern Baltic cod, Gadus morhua, caught in the Bornholm Basin between 1996 and 2019. The ear stones record annual growth in some fish species, similar to tree rings, making them valuable timekeepers.
They specifically looked into the growth trends of the cod over 25 years of heavy fishing and compared the changes with genetic alterations found in the species at the full genome level.
The study revealed a '48 per cent decrease in asymptotic body length' of the cod from 1996 to 2019, with indications that the species had evolved due to human interference.
Genetic variations in the cod associated with body growth showed signs of 'directional selection', researchers pointed out.
Some structural changes in the genome seemed to indicate environmental adaptation, hinting the "shrinking" had a genetic basis tied to human activity.
"Selective overexploitation has altered the genome of Eastern Baltic cod," Dr Han explained. "We see this in the significant decline in average size, which we could link to reduced growth rates.'
The study found the genomes of fast-growing cod differed systematically from slow growers, with the fast growers nearly disappearing from the Baltic.
"When the largest individuals are consistently removed from the population over many years, smaller, faster-maturing fish gain an evolutionary advantage," Thorsten Reusch, another author of the study, said. "What we're observing is evolution in action, driven by human activity. This is scientifically fascinating, but ecologically deeply concerning.'
The new research calls for conservation policies to look into the adaptive potential of marine species.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tom Holland, Jacob Elordi and Harris Dickinson at top of James Bond wishlist
Tom Holland, Jacob Elordi and Harris Dickinson at top of James Bond wishlist

The Guardian

time17 hours ago

  • The Guardian

Tom Holland, Jacob Elordi and Harris Dickinson at top of James Bond wishlist

Tom Holland, Harris Dickinson and Jacob Elordi are rumoured to be at the top of Amazon's James Bond wishlist, according to a new report. Variety has learned from insiders that the new iteration of 007 would be under 30 and the three actors could be fighting it out for the role. No meetings have taken place and Amazon has yet to confirm anything. The report emerges days after the Dune and Arrival director Denis Villeneuve was announced as the first director of Bond's new era under the Amazon-MGM banner. The French-Canadian film-maker, now working on the third Dune movie, reportedly beat out Conclave's Edward Berger, Westworld's Jonathan Nolan, Paddington's Paul King and Shaun of the Dead's Edgar Wright for the role. 'I intend to honour the tradition and open the path for many new missions to come,' Villeneuve said in a statement. 'This is a massive responsibility, but also, incredibly exciting for me and a huge honour.' Early rumours had suggested the Gravity director Alfonso Cuarón would step up, having worked with Bond's new producer David Heyman before, but he removed himself from the race. Cuarón is set to work on the darkly funny drama Jane with Charlize Theron instead. Holland, best known for playing Spider-Man, has also starred in the video game hit Uncharted and Apple series The Crowded Room. He'll next be seen in Christopher Nolan's The Odyssey before returning for the fourth Spider-Man movie. The 29-year-old actor once tried to pitch a 007 spin-off to Sony. 'I had a meeting after or during Spider-Man 2 with Sony to pitch this idea of a young Bond film that I'd come up with,' he said in 2022. 'It was the origin story of James Bond. It didn't really make sense. It didn't work. It was the dream of a young kid, and I don't think the Bond estate were particularly interested.' Dickinson, known for Triangle of Sadness and Babygirl, recently received rave reviews for his directorial debut Urchin at the Cannes film festival. 'I mean, listen, man, you'd be a fool to not entertain that role,' he said when asked about playing Bond in 2023. 'I'm loving seeing the development of James Bond and seeing how it changes over the years. I think Daniel Craig was such a good Bond that I'd almost be quite frightened to try … Who knows what they're doing with Bond? I'm intrigued.' Elordi is the only Australian of the bunch, but could follow in the footsteps of George Lazenby who played Bond in On Her Majesty's Secret Service. The actor, best known for his role in TV drama Euphoria and Sofia Coppola's Priscilla, will soon be seen in Emerald Fennell's unconventional adaptation of Wuthering Heights with Margot Robbie. In 2023, Elordi called rumours that he was being linked to the role 'beautiful' and added: 'I just like that people maybe want to put me in their movies. That makes me really glad.' The release date for the next film is yet to be announced, but Variety is claiming that anything sooner than 2028 would be impossible. The 26th Bond film will follow Daniel Craig's final outing No Time to Die which made over $774m at the global box office. Earlier this year, in a reported $1bn deal, Amazon MGM bought the rights to gain 'creative control' of the franchise. In March, producers Amy Pascal and David Heyman were hired to take charge of the new film.

Ethical questions surround the NHS sampling babies' DNA
Ethical questions surround the NHS sampling babies' DNA

The Guardian

time18 hours ago

  • The Guardian

Ethical questions surround the NHS sampling babies' DNA

Re your report (All babies in England to get DNA test to assess risk of diseases within 10 years, 20 June), the NHS plans to test the DNA of all babies to 'assess disease risk', in association with AI, having already sampled 100,000 newborns. The Department of Health and Social Care said that genomics and AI would be used to 'revolutionise prevention' and provide faster diagnoses and an 'early warning signal for disease'. In line with previous predictions, when individuals who submitted to a PCR test (which amplifies genetic material) during Covid-19 had their DNA sold for profit without their consent, infants now face their private, personal, biological data being captured, stored and used by who-knows-what corporations on behalf of the NHS. Not everyone wants to know what potential diseases they might suffer from in the future, especially if there is no known treatment. And for what purposes might it be used, other than 'prediction of disease risk'? Testing of new drugs? Testing of vaccines? Clearly an infant cannot give consent to its DNA being used for these purposes and research on children is unethical unless they stand to benefit. Will parents have the opportunity to give informed consent and can it even be informed if they are unaware of the many potential uses of the material? A global genomics market of $32.65bn in 2023 suggests that this is big business. Genomics England already makes available patients' genomic data to businesses. The association with AI additionally raises the spectre of surveillance in the form of digital IDs, incorporating not only biometric data, such as fingerprints, retinal scans and facial recognition, but potentially even the human genome itself. The NHS data of 57 million patients has already been used to train AI outside of the intended purpose. Will doctors recognise these risks and take steps to inform patients? Or will technology roll on regardless?Janet MenageRetired GP, Llanybydder, Ceredigion Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.

How plaque and gum disease can lead to dementia: As doctors unveil startling research, experts reveal ultimate guide to the brushes, floss and toothpaste that really work to keep you healthy
How plaque and gum disease can lead to dementia: As doctors unveil startling research, experts reveal ultimate guide to the brushes, floss and toothpaste that really work to keep you healthy

Daily Mail​

time19 hours ago

  • Daily Mail​

How plaque and gum disease can lead to dementia: As doctors unveil startling research, experts reveal ultimate guide to the brushes, floss and toothpaste that really work to keep you healthy

If eyes are the window to the soul, then the mouth is a portal to the mind, according to the British Dental Association. 'There's emerging evidence that poor oral health – plaque formation, gum disease and tooth loss – is a risk factor for dementia, including Alzheimer's disease,' says Eddie Crouch, the association's chair. A slew of recent research suggests that what happens in your mouth can have wider health implications. Several large studies have discovered links between periodontitis (that's chronic gum disease to you and me) and an increased risk of cognitive decline.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store